Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 10 of 10 entries
View as:

TP05 for the Treatment of Mild to Moderate Active Ulcerative Colitis (UC)

Phase: N/A Priority: Normal
NCT ID: NCT01903252 Org: User:
Start: 07/31/13 End: 11/30/16 Due: 11/30/17

TP0501 - Pharmaco-Scintigraphic-Study

Phase: N/A Priority: Normal
NCT ID: NCT02306772 Org: User:
Start: 12/31/11 End: 03/31/12 Due: 03/31/13

Comparative Efficacy and Safety Study in Patients With Ulcerative Colitis in Remission Phase

Phase: N/A Priority: Normal
NCT ID: NCT01257399 Org: User:
Start: 11/30/10 End: 03/31/13 Due: 03/31/14

An Efficacy and Safety Study of Omega-3 Free Fatty Acids (Epanova™) for the Maintenance of Symptomatic Remission in Subjects With Crohn's Disease

Phase: N/A Priority: Normal
NCT ID: NCT00074542 Org: User:
Start: 09/30/02 End: 01/31/05 Due: 01/31/06

Comparative Efficacy and Safety Study in Patients With Active Ulcerative Colitis

Phase: N/A Priority: Normal
NCT ID: NCT01257386 Org: User:
Start: 11/30/10 End: 03/31/13 Due: 03/31/14

TP0502-Pharmaco-Scintigraphic-Study and Amendment

Phase: N/A Priority: Normal
NCT ID: NCT02306785 Org: User:
Start: 10/31/12 End: 06/30/13 Due: 06/30/14

Pharmaco-Scintigraphic Study to Evaluate the Release Profile of Metronidazole Benzoate Capsules

Phase: N/A Priority: Normal
NCT ID: NCT02911298 Org: User:
Start: 11/25/16 End: 03/06/17 Due: 03/06/18

TP0502-B-Pharmaco-Scintigraphic-Study

Phase: N/A Priority: Normal
NCT ID: NCT02306798 Org: User:
Start: 09/30/13 End: 12/31/13 Due: 12/31/14

Efficacy and Safety of Asacol™ 4.8 g/Day (800 mg Tablets) for the Treatment of Active Ulcerative Colitis

Phase: N/A Priority: Normal
NCT ID: NCT01059344 Org: User:
Start: 11/30/09 End: 08/31/11 Due: 08/31/12

EPANOVA in Crohn's Disease, Study 1

Phase: N/A Priority: Normal
NCT ID: NCT00613197 Org: User:
Start: 01/31/03 End: 08/31/06 Due: 08/31/07